Active substance
Phenobarbital
- US FDA 1
- Health Canada 11
- US price lines 10
- NHS prices 7
- WHO EML 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SEZABY | 100MG/VIAL | powder · intravenous | SUN PHARM INDS INC | Prescription | 17 Nov 2022 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP PHENOBARBITAL | 02557789 | 15 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP PHENOBARBITAL | 02557797 | 30 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP PHENOBARBITAL | 02557800 | 60 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP PHENOBARBITAL | 02557819 | 100 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| PHENOBARBITAL SODIUM INJECTION, USP | 02304082 | 30 MG / ML | SOLUTION · INTRAMUSCULAR; INTRAVENOUS | SANDOZ CANADA INCORPORATED |
| PHENOBARBITAL SODIUM INJECTION, USP | 02304090 | 120 MG / ML | SOLUTION · INTRAMUSCULAR; INTRAVENOUS | SANDOZ CANADA INCORPORATED |
| PMS-PHENOBARBITAL | 00178799 | 15 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PHENOBARBITAL | 00178802 | 30 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PHENOBARBITAL | 00178810 | 60 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PHENOBARBITAL | 00178829 | 100 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PHENOBARBITAL ELIXIR | 00645575 | 5 MG / ML | SOLUTION · ORAL | PHARMASCIENCE INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | PHENOBARBITAL 100 MG TABLET | $0.21266 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 15 MG TABLET | $0.07659 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 16.2 MG TABLET | $0.0559 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 20 MG/5 ML ELIX | $0.04697 | per ML | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 20 MG/5 ML SOLN | $0.04697 | per ML | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 30 MG TABLET | $0.14164 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 32.4 MG TABLET | $0.07856 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 60 MG TABLET | $0.18086 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 64.8 MG TABLET | $0.10159 | per EA | 23 Sep 2026 |
| US NADAC | PHENOBARBITAL 97.2 MG TABLET | $0.11769 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Phenobarbital 15mg tablets | £6.44 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 15mg/5ml elixir | £83.00 | 500 ml | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 200mg/1ml solution for injection ampoules | £149.15 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 30mg tablets | £1.76 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 30mg/1ml solution for injection ampoules | £181.74 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 60mg tablets | £3.64 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Phenobarbital 60mg/1ml solution for injection ampoules | £197.01 | 10 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 5.1.1. Antiseizure medicines · core
Status epilepticus; Epilepsy or seizures
Parenteral > General injections > IV: 200 mg per mL (phenobarbital sodium); 30 mg per mL (phenobarbital sodium) (EMLc); 60 mg per mL (phenobarbital sodium) (EMLc) | Oral > Liquid: 15 mg per 5 mL | Oral > Solid > tablet: 15 mg; 30 mg; 60 mg; 100 mg
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.